Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
出版年份 2013 全文链接
标题
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 16, Pages E1490-E1499
出版商
Proceedings of the National Academy of Sciences
发表日期
2013-04-02
DOI
10.1073/pnas.1219992110
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics
- (2012) Housheng Hansen He et al. GENOME RESEARCH
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer
- (2012) B. Akhtar-Zaidi et al. SCIENCE
- Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
- (2011) Seho Park et al. BREAST
- AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription
- (2011) Si Kee Tan et al. EMBO JOURNAL
- Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions
- (2011) Gabriel E. Zentner et al. GENOME RESEARCH
- Correlation of Histologic Grade With Other Clinicopathological Parameters, Intrinsic Subtype, and Patients' Clinical Outcome in Taiwanese Women
- (2011) S.-T. Chen et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
- (2011) Kevin C. Wang et al. NATURE
- Mapping and analysis of chromatin state dynamics in nine human cell types
- (2011) Jason Ernst et al. NATURE
- A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
- (2011) Markus K Muellner et al. Nature Chemical Biology
- Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes
- (2011) Javier Rodríguez-Ubreva et al. NUCLEIC ACIDS RESEARCH
- Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells
- (2011) K. A. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition
- (2011) L.-A. Martin et al. STEROIDS
- ER -Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer
- (2011) T. W. Miller et al. Cancer Discovery
- PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
- (2011) Luca Magnani et al. PLoS Genetics
- Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases
- (2010) Simak Ali et al. Annual Review of Medicine
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
- (2010) C. L. Efferson et al. CANCER RESEARCH
- Epigenetic reprogramming — taking a lesson from the embryo
- (2010) Petra Hajkova CURRENT OPINION IN CELL BIOLOGY
- Growth factor stimulation induces a distinct ER cistrome underlying breast cancer endocrine resistance
- (2010) M. Lupien et al. GENES & DEVELOPMENT
- A CTCF-independent role for cohesin in tissue-specific transcription
- (2010) D. Schmidt et al. GENOME RESEARCH
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- The importance of gene-centring microarray data
- (2010) Therese Sørlie et al. LANCET ONCOLOGY
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- A unique chromatin signature uncovers early developmental enhancers in humans
- (2010) Alvaro Rada-Iglesias et al. NATURE
- Discovery and characterization of chromatin states for systematic annotation of the human genome
- (2010) Jason Ernst et al. NATURE BIOTECHNOLOGY
- GREAT improves functional interpretation of cis-regulatory regions
- (2010) Cory Y McLean et al. NATURE BIOTECHNOLOGY
- FOXA1 is a key determinant of estrogen receptor function and endocrine response
- (2010) Antoni Hurtado et al. NATURE GENETICS
- EpiChIP: gene-by-gene quantification of epigenetic modification levels
- (2010) Daniel Hebenstreit et al. NUCLEIC ACIDS RESEARCH
- Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
- (2010) H Aguilar et al. ONCOGENE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- De novo Discovery of a -Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model
- (2009) J. W. Watters et al. CANCER RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
- (2009) J. Eeckhoute et al. GENOME RESEARCH
- Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
- (2009) J. M. Flanagan et al. MOLECULAR CANCER THERAPEUTICS
- Histone modifications at human enhancers reflect global cell-type-specific gene expression
- (2009) Nathaniel D. Heintzman et al. NATURE
- ChIP-seq accurately predicts tissue-specific activity of enhancers
- (2009) Axel Visel et al. NATURE
- Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor
- (2009) K. R. Coser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of cancer cell proliferation by designed peptide amphiphiles
- (2008) Lorenzo Aulisa et al. Acta Biomaterialia
- The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery
- (2008) Takayoshi Kiba et al. BMC CANCER
- Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts
- (2008) C. J. Creighton et al. CANCER RESEARCH
- Identification ofPbx1, a Potential Oncogene, as a Notch3 Target Gene in Ovarian Cancer
- (2008) Joon T. Park et al. CANCER RESEARCH
- Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
- (2008) P. Rizzo et al. CANCER RESEARCH
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
- (2008) Mathieu Lupien et al. CELL
- Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT
- (2008) Stephen Chia et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
- (2008) Antoni Hurtado et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started